Analysis of A2a receptor-deficient mice reveals no significant compensatory increases in the expression of A2b, A1, and A3 adenosine receptors in lymphoid organs

Biochemical Pharmacology

Volumn 65, Issue 12, 2003, Pages 2081-2090

  Lukashev, Dmitriy E ^a   Smith, Patrick T ^a   Caldwell, Charles C ^a   Ohta, Akio ^a   Apasov, Sergey G ^a   Sitkovsky, Michail V ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Adenosine; Adenosine receptors; Cyclic AMP; Inflammation

Indexed keywords

ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; CYCLIC AMP; CYTOKINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; INFLAMMATION; LYMPH NODE; LYMPHOID ORGAN; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; SPLEEN CELL; THYMUS; TISSUE INJURY; UPREGULATION;

EID: 0038392350     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00158-8     Document Type: Article

References (25)

1. Holloway A.F., Rao S., Shannon M.F. Regulation of cytokine gene transcription in the immune system. Mol. Immunol. 38:2002;567-580.
2. Tarkowski A., Wagner H. Arthritis and sepsis caused by Staphylococcus aureus: can the tissue injury be reduced by modulating the host's immune system. Mol. Med. Today. 4:1998;15-18.
3. Shacter E., Weitzman S.A. Chronic inflammation and cancer. Oncology (Huntingt.). 16:2002;217-226.
4. 2A receptor stimulation reduces inflammation and neointimal growth in a murine carotid ligation model. Arterioscler. Thromb. Vasc. Biol. 21:2001;791-796.
5. Pockley A.G. Heat shock proteins, inflammation, and cardiovascular disease. Circulation. 105:2002;1012-1027.
6. Shebuski R.J., Kilgore K.S. Role of inflammatory mediators in thrombogenesis. J. Pharmacol. Exp. Ther. 300:2002;729-735.
7. Mulvihill N.T., Foley J.B. Inflammation in acute coronary syndromes. Heart. 87:2002;201-204.
8. Levy B.D., Clish C.B., Schmidt B., Gronert K., Serhan C.N. Lipid mediator class switching during acute inflammation: signals in resolution. Nat. Immunol. 2:2001;612-619.
9. Savill J. Apoptosis in resolution of inflammation. Kidney Blood Press. Res. 23:2002;173-174.
10. Harris S.G., Padilla J., Koumas L., Ray D., Phipps R.P. Prostaglandins as modulators of immunity. Trends Immunol. 23:2002;144-150.
11. Gilroy D.W., Colville-Nash P.R., Willis D., Chivers J., Paul-Clark M.J., Willoughby D.A. Inducible cyclooxygenase may have anti-inflammatory properties. Nat. Med. 5:1999;698-701.
12. Neeck G., Kluter A., Dotzlaw H., Eggert M. Involvement of the glucocorticoid receptor in the pathogenesis of rheumatoid arthritis. Ann. N.Y. Acad. Sci. 966:2002;491-495.
13. Klinger M., Freissmuth M., Nanoff C. Adenosine receptors: G protein-mediated signalling and the role of accessory proteins. Cell Signal. 14:2002;99-108.
14. Linden J. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu. Rev. Pharmacol. Toxicol. 41:2001;775-787.
15. Rudolphi K.A., Schubert P., Parkinson F.E., Fredholm B.B. Neuroprotective role of adenosine in cerebral ischaemia. Trends Pharmacol. Sci. 13:1992;439-445.
16. Cronstein B.N., Naime D., Ostad E. The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J. Clin. Invest. 92:1993;2675-2682.
17. Cronstein B.N. A novel approach to the development of anti-inflammatory agents: adenosine release at the inflamed sites. J. Investig. Med. 43:1995;50-57.
18. Huang S., Apasov S., Koshiba M., Sitkovsky M. Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood. 90:1997;1600-1610.
19. Ohta A., Sitkovsky M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature. 414:2001;916-920.
20. Mubagwa K., Flameng W. Adenosine, adenosine receptors and myocardial protection: an updated overview. Cardiovasc. Res. 52:2001;25-39.
21. Chen J.-F., Huang Z., Ma J., Zhu J., Moratalla R., Standaert D., Moskowitz M.A., Fink J.S., Schwartzschild M.A. A2A adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J. Neurosci. 19:1999;9192-9200.
22. 2A receptor-unrelated lymphotoxicity. Br. J. Pharmacol. 131:2000;43-50.
23. Thellin O., Zorzi W., Lakaye B., De Borman B., Coumans B., Hennen G., Grisar T., Igout A., Heinen E. Housekeeping genes as internal standards: use and limits. J. Biotechnol. 75:1999;291-295.
24. Bustin S.A. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J. Mol. Endocrinol. 25:2002;169-193.
25. Zhao Z., Francis C., Ravid K. Characterization of the mouse A3 adenosine receptor gene: exon/intron organization and promoter activity. Genomics. 57:1999;152-155.